These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17917041)

  • 1. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity.
    Holland SM
    Immunol Res; 2007; 38(1-3):342-6. PubMed ID: 17917041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mendelian predisposition to mycobacterial infections in humans].
    Casanova JL
    J Soc Biol; 2000; 194(1):25-8. PubMed ID: 11107546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma and interleukin-12 pathway defects and human disease.
    Dorman SE; Holland SM
    Cytokine Growth Factor Rev; 2000 Dec; 11(4):321-33. PubMed ID: 10959079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling.
    Haverkamp MH; van Dissel JT; Holland SM
    Microbes Infect; 2006 Apr; 8(4):1157-66. PubMed ID: 16520075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
    Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S
    Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood.
    Remus N; Reichenbach J; Picard C; Rietschel C; Wood P; Lammas D; Kumararatne DS; Casanova JL
    Pediatr Res; 2001 Jul; 50(1):8-13. PubMed ID: 11420412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From gene to disease; mutations in interleukin-12-receptor-beta 1- and interferon-gamma-receptor-1 lead to nontuberculous mycobacterial infections and salmonellosis].
    van Dissel JT; Ottenhoff TH
    Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1830-2. PubMed ID: 11020837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mendelian susceptibility to mycobacterial infection in man.
    Altare F; Jouanguy E; Lamhamedi S; Döffinger R; Fischer A; Casanova JL
    Curr Opin Immunol; 1998 Aug; 10(4):413-7. PubMed ID: 9722917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of human host immunity to mycobacteria.
    Ottenhoff TH; Verreck FA; Hoeve MA; van de Vosse E
    Tuberculosis (Edinb); 2005; 85(1-2):53-64. PubMed ID: 15687028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae.
    van de Vosse E; Hoeve MA; Ottenhoff TH
    Lancet Infect Dis; 2004 Dec; 4(12):739-49. PubMed ID: 15567123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
    Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
    J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mendelian susceptibility to mycobacterial infection in man.
    Casanova JL
    Swiss Med Wkly; 2001 Aug; 131(31-32):445-54. PubMed ID: 11641967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases.
    Qu HQ; Fisher-Hoch SP; McCormick JB
    Int J Infect Dis; 2011 May; 15(5):e305-13. PubMed ID: 21330176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity.
    van de Vosse E; Ottenhoff TH
    Microbes Infect; 2006 Apr; 8(4):1167-73. PubMed ID: 16513390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection.
    Döffinger R; Altare F; Casanova JL
    Microbes Infect; 2000 Nov; 2(13):1553-7. PubMed ID: 11113374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects in the interferon-gamma and interleukin-12 pathways.
    Rosenzweig SD; Holland SM
    Immunol Rev; 2005 Feb; 203():38-47. PubMed ID: 15661020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.
    Ottenhoff TH; Verreck FA; Lichtenauer-Kaligis EG; Hoeve MA; Sanal O; van Dissel JT
    Nat Genet; 2002 Sep; 32(1):97-105. PubMed ID: 12205477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.
    Wu UI; Holland SM
    Semin Immunopathol; 2016 Mar; 38(2):199-212. PubMed ID: 26733044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically determined susceptibility to mycobacterial infection.
    Patel SY; Doffinger R; Barcenas-Morales G; Kumararatne DS
    J Clin Pathol; 2008 Sep; 61(9):1006-12. PubMed ID: 18326015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update.
    Döffinger R; Dupuis S; Picard C; Fieschi C; Feinberg J; Barcenas-Morales G; Casanova JL
    Mol Immunol; 2002 May; 38(12-13):903-9. PubMed ID: 12009568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.